Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease

BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) and soluble urokinase-type plasminogen activator receptor (suPAR) participate in inflammation and tissue remolding in various diseases, but their roles in chronic obstructive pulmonary disease (COPD) are not yet clear. This study aimed to investi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Chron Obstruct Pulmon Dis
Main Authors: Wang, Hao, Yang, Ting, Li, Diandian, Wu, Yanqiu, Zhang, Xue, Pang, Caishuang, Zhang, Junlong, Ying, Binwu, Wang, Tao, Wen, Fuqiang
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2016
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044991/
https://ncbi.nlm.nih.gov/pubmed/27713627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S107409
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares